Expanding regulatory requirements for poultry producers in the United States to curb water pollution

2002 ◽  
Vol 58 (4) ◽  
pp. 559-566 ◽  
Author(s):  
T.J. Centner
1997 ◽  
Vol 74 (12) ◽  
pp. 1413 ◽  
Author(s):  
Paul B. Kelter ◽  
Julie Grundman ◽  
David S. Hage ◽  
James D. Carr ◽  
Carlos Mauricio Castro-Acuña

2021 ◽  
Vol 25 (1) ◽  
pp. 32-40
Author(s):  
О.S. Popov ◽  
І.V. Kravchenko ◽  
V.Ye. Dоbrоvа ◽  
K.M. Tkachenko

Providing the population of Ukraine with quality, effective and, at the same time, economically affordable medicines is a priority task of the healthcare system. Taking into account the relatively low cost of their development generic drugs are available to the majority of the country’s population; thus, bioequivalence studies are needed to obtain data on their efficacy and safety. Ukraine is currently in the process of harmonizing domestic regulatory requirements for generic drugs and conducting bioequivalence studies with global ones. Therefore, it is important to find out the differences in approaches to the registration of generics and studies of their bioequivalence in Ukraine and other countries. Another important aspect is to provide the policy of “transparency” of bioequivalence research results, which contributes to the use of better drugs. Aim. To analyze domestic and global approaches to the organization of the bioequivalence research and provide the policy of “transparency” of their results. Materials and methods. A comparative analysis of approaches to drug registration, requirements for generic drugs and bioequivalence studies and ways to provide the policy of “transparency” of their results in Ukraine, the United States and the European Union was conducted. Results. The analysis has revealed that the methods of registration of drugs in Ukraine, the United States and the EU are the same. Approaches to providing the “transparency” of the results of bioequivalence studies differ since in Ukraine the publication of such information is not mandatory and is at the discretion of pharmaceutical manufacturers. Conclusions. Domestic regulatory requirements for assessing generic drugs are harmonized with the world ones. Today, there is a need to introduce a mandatory requirement for the publication of bioequivalence studies, and it will contribute to providing an effective “transparency” policy.


2014 ◽  
Vol 16 (4) ◽  
pp. 797-804

<div> <p>Non-point sources pollution from highway runoff is among the most important reasons for surface and ground waters degradation. Atmospheric deposition, exhaust emissions, pavement wear and tire wear all have been found to be crucial pollutants in highway runoff. The most critical pollutants included in the runoff of interurban roads such as total suspended solids, heavy metals, chlorides and nutrients, together with the factors affecting their concentration are been investigated. Existing legislation about drainage and highway stormwater management in United States and European Union as well as the federal agencies of the United States which have the responsibility to regulate drainage and stormwater management are also presented. Water pollution concerns in the Unites States are mainly addressed through the Federal Water Pollution Control Act of 1972, known as the Clean Water Act. Provisions within the Clean Water Act require all states to implement regulations in order to reduce the pollutant mass loading prior to discharging into water recipients. In European Union the Water Framework Directive 2000/60/EC sets common goals for the water management and created an overall water policy for management at an international level.</p> </div> <p>&nbsp;</p>


2001 ◽  
Vol 64 (4) ◽  
pp. 503-508 ◽  
Author(s):  
E. A. DUFFY ◽  
K. E. BELK ◽  
J. N. SOFOS ◽  
S. B. LeVALLEY ◽  
M. L. KAIN ◽  
...  

Lamb carcasses (n = 5,042) were sampled from six major lamb packing facilities in the United States over 3 days during each of two visits (fall or winter, October through February; spring, March through June) in order to develop a microbiological baseline for the incidence (presence or absence) of Salmonella spp. and for populations of Escherichia coli after 24 h of chilling following slaughter. Samples also were analyzed for aerobic plate counts (APC) and total coliform counts (TCC). Additionally, incidence (presence or absence) of Campylobacter jejuni/coli on lamb carcasses (n = 2,226) was determined during the slaughtering process and in the cooler. All samples were obtained by sponge-sampling the muscle-adipose tissue surface of the flank, breast, and leg of lamb carcasses (100 cm2 per site; 300 cm2 total). Incidence of Salmonella spp. in samples collected from chilled carcasses was 1.5% for both seasons combined, with 1.9% and 1.2% of fall or winter and spring samples being positive, respectively. Mean (log CFU/cm2) APC, TCC, and E. coli counts (ECC) on chilled lamb carcasses across both seasons were 4.42, 1.18, and 0.70, respectively. APC were lower (P &lt; 0.05) in samples collected in the spring versus fall or winter, while TCC were higher in samples collected in the spring. There was no difference (P &gt; 0.05) between ECC from samples collected in the spring versus winter. Only 7 out of 2,226 total samples (0.3%) tested positive for C. jejuni/coli, across all sampling sites. These results should be useful to the lamb industry and regulatory authorities as new regulatory requirements for meat inspection become effective.


Sign in / Sign up

Export Citation Format

Share Document